Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.
about
Dipeptidyl Peptidase 4 Inhibitors and the Risk of Cardiovascular Disease in Patients with Type 2 Diabetes: A Tale of Three StudiesGlucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of strokeAssessing the efficacy and safety of combined DPP-4 inhibitor and insulin treatment in patients with type 2 diabetes: a meta-analysisSAVOR-TIMI to SUSTAIN-6: a critical comparison of cardiovascular outcome trials of antidiabetic drugs.Effects of SGLT-2 inhibitors on mortality and cardiovascular events: a comprehensive meta-analysis of randomized controlled trials.Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.The effect of sitagliptin on cardiovascular risk profile in Korean patients with type 2 diabetes mellitus: a retrospective cohort studyEffectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study.Risk for Hospitalized Heart Failure Among New Users of Saxagliptin, Sitagliptin, and Other Antihyperglycemic Drugs: A Retrospective Cohort StudySafety of dipeptidyl peptidase-4 inhibitors for treating type 2 diabetes.Managing comorbidities in patients with chronic heart failure: first, do no harm.Dipeptidyl peptidase-4 inhibitor use in patients with type 2 diabetes and cardiovascular disease or risk factors.No increased risk of cardiovascular events in older adults initiating dipeptidyl peptidase-4 inhibitors vs therapeutic alternatives.Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials.Identification of predictors of response to basal insulin and DPP4 inhibitors in patients with type 2 diabetes failing to other therapies.Heart failure hospitalization risk associated with use of two classes of oral antidiabetic medications: an observational, real-world analysis.Comparative cardiovascular risks of dipeptidyl peptidase 4 inhibitors with other second- and third-line antidiabetic drugs in patients with type 2 diabetes.
P2860
Q26777177-C0E0A91A-C125-4105-838C-A4613B5C9417Q26861493-B714E5DA-0630-4903-8C8F-2CE36EC279ECQ28075335-6C3AA0F6-CEDE-4BEE-BB79-70DCA2A4F0BFQ30238791-36859DFC-A66C-43B9-95E8-4F46454E82DEQ30248634-698F89F4-41F6-47D8-B617-8E30E55552E7Q36639308-E4FA4095-41F4-44E8-A389-6210F503DFF9Q36710078-943CC3BB-8494-4E67-9854-97C59321F44DQ37145172-E81B51D3-2964-4C30-8431-6EC3A11BBC40Q37527438-5E8729C5-3D31-47A0-89A9-BBEF1E32D1C7Q38335751-2E91765A-B306-4E2E-98F6-203A85E7DED0Q38402807-15F164E9-EC75-459D-BA71-3FEE7811F57EQ38599145-D0355847-CA6D-48EB-9643-5C809A9A2D2AQ38962521-DA2C4192-14DC-4981-89F8-303520437362Q39350860-20AFE7A4-D2CD-4215-8108-5F6BF56CB4FEQ39870068-AEA5D571-FADE-4C3A-8E45-75698ACD2B7CQ41168197-BC84C967-147D-40F4-A02B-8263522A1277Q41176211-039703B8-43C9-452D-88FC-FFF09FAE6929Q50941572-2B0BCE40-7DD6-4446-9D50-7CEAB18D58E8
P2860
Dipeptidyl peptidase-4 inhibitors do not increase the risk of cardiovascular events in type 2 diabetes: a cohort study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.
@ast
Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.
@en
Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.
@nl
type
label
Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.
@ast
Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.
@en
Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.
@nl
prefLabel
Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.
@ast
Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.
@en
Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.
@nl
P2093
P2860
P1433
P1476
Dipeptidyl peptidase-4 inhibit ...... pe 2 diabetes: a cohort study.
@en
P2093
Allison B Goldfine
Brendan M Everett
Robert J Glynn
P2860
P2888
P304
P356
10.1007/S00592-014-0663-2
P577
2014-10-14T00:00:00Z
P6179
1009834390